COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations through December 31, 2020.

Live Webcast - Mayo Clinic Multiple Sclerosis and Autoimmune Neurology 2019

February 8, 2019 to February 9, 2019

Course Directors: Dean M. Wingerchuk, M.D.Jonathan L. Carter, M.D. and Eoin P. Flanagan, M.B., B.Ch.

This state-of-the-art update on Multiple Sclerosis and Autoimmune Neurology is designed to provide Evidence-Based Strategies that focus on practical clinical management from a multidisciplinary approach when treating patients with these neurologic disorders. We welcome a variety of specialists, primary care physicians, and advanced health care providers who have a specific interest in this field. Intended Audience: Neurologists and all health care providers who treat patients with neurologic disorders. The format will include the latest clinical and laboratory research presented through didactic lecture, case vignettes, interactive Q & A sessions, and the opportunity for open discussions with the faculty.

Course Highlights:

  • Evidence-Based Case Presentations
  • Multidisciplinary Focus
  • Expert Mayo and Guest Faculty

Live Course Option Available

This page is for the webcast version of the course. If you're interested in attending in person, please visit the page for the live course.

NOTE: This "live-stream" webcast takes place in Arizona, which is in (MST) Mountain Standard time. Please adjust your schedule to participate accordingly. Time Zone Converter Tool

Webcast Registration Fee

Registration Fee



Target Audience

This course is designed to update the entire multidisciplinary team, including neurologists, primary care physicians, nurse practitioners, physician assistants, nurses, physical therapists, occupational therapists and all health care providers who treat patients with neurologic disorders.

Learning Objectives

Upon conclusion of this program, participants should be able to:

  • Cite the mechanism of action, indications, and adverse events associated with recently-approved MS and autoimmune neurology disease-modifying therapies.
  • Describe the clinical, laboratory and neuroimaging characteristics of neuromyelitis optica spectrum disorders.
  • Implement strategies for selecting first and subsequent disease-modifying therapies for patients with relapsing or progressive MS.
  • Describe the clinical, laboratory and neuroimaging characteristics of myelin oligodendrocyte glycoprotein-associated disorders.
  • Identify appropriate management of common MS symptoms.

Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit
  • 11.00 AOA Category 2-A
  • 11.00 Attendance
Event starts: 
02/08/2019 - 12:00pm
Event ends: 
02/09/2019 - 4:15pm

Click here to view Program Schedule on mobile


Guest Faculty


Ellen M. Mowry, M.D., M.C.R. 
Associate Professor of Neurology and Epidemiology 
Johns Hopkins University
Baltimore, MD

Howard L. Weiner, M.D.
Robert L. Kroc Professor of Neurology, Harvard Medical School
Director, Partners Multiple Sclerosis Center and Co-Director,
Center for Neurologic Diseases, Brigham and Women's Hospital,
Boston, MA

Mayo Clinic Faculty

Jonathan L. Carter, M.D.*
Iris V. Marin Collazo, M.D.
Divyanshu Dubey, M.B.BS.
Eoin P. Flanagan, M.C., B.Ch.*
Ralitza H. Gavrilova, M.D.
Orhun H. Kantarci, M.D.
B. Mark Keegan, M.D.
Claudia F. Lucchinetti, M.D.
Andrew McKeon, M.D. , M.B., B.Ch.
Sean J. Pittock,  M.D.
Jan-Mendelt Tillema, M.D.
W. Oliver Tobin, M.B., B.Ch., BAO, Ph.D.
Michel Toledano, M.D.
Brian G. Weinshenker, M.D.
Dean M. Wingerchuk , M.D. *
Nicholas L. Zalewski, M.D.
Anastasia Zekeridou, M.D.

*Course Directors

Accreditation Statement:

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Live activity, 2019 Multiple Sclerosis & Autoimmune Update, with a beginning date of 02/08/2019, has been reviewed and
is acceptable for up to  11.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim
only the credit commensurate with the extent of their participation in the activity.

This program has been accredited by the American Osteopathic Association for 11.00 credits of AOA Category 2-A.

Other Healthcare Professionals
A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Available Credit

  • 11.00 AMA PRA Category 1 Credit
  • 11.00 AOA Category 2-A
  • 11.00 Attendance


Please login or register to take this course.

Cancellation and Refund Policy:

Request for cancellations must be submitted in writing to When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.

Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.